Overview
I specialize in the management of infections in immunocompromised patients including but not limited to patients prior to and following solid organ transplantation, and patients with hematological malignancies complicated by infection. I am particularly interested in assessing risk factors for infections, optimizing diagnostics, and providing patient-centered clinical care in immunocompromised hosts.
Current Duke Appointments & Affiliations
Assistant Professor of Medicine
·
2022 - Present
Medicine, Infectious Diseases,
Medicine
Recent Scholarly Works
Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancy.
Journal article Transpl Infect Dis · May 12, 2026 Full text Link to item CiteMusculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates.
Journal article Transplant Cell Ther · May 2026 Chimeric antigen receptor T-cell (CAR-T) therapy targeting B-cell maturation antigen (BCMA) has revolutionized treatment for relapsed/refractory multiple myeloma (RRMM). While life-threatening toxicities like cytokine release syndrome and immune effector c ... Full text Link to item CiteImpact of HeartMate 3 left ventricular assist device infection on outcomes following heart transplant.
Journal article J Heart Lung Transplant · April 2026 BACKGROUND: Infectious complications are common in patients implanted with HeartMate 3 (HM3) left ventricular assist devices (LVAD). Despite these issues, some patients with LVAD-specific infection are ultimately considered for heart transplant (HT). The i ... Full text Link to item CiteEducation
University of Wollongong (Australia) ·
2012
M.B.B.S.